| pubmed-article:8381868 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8381868 | lifeskim:mentions | umls-concept:C0199176 | lld:lifeskim |
| pubmed-article:8381868 | lifeskim:mentions | umls-concept:C0750572 | lld:lifeskim |
| pubmed-article:8381868 | lifeskim:mentions | umls-concept:C1963724 | lld:lifeskim |
| pubmed-article:8381868 | lifeskim:mentions | umls-concept:C0036152 | lld:lifeskim |
| pubmed-article:8381868 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:8381868 | pubmed:dateCreated | 1993-3-15 | lld:pubmed |
| pubmed-article:8381868 | pubmed:abstractText | Using data from the San Francisco Men's Health Study and the San Francisco General Hospital Cohort, we derived partially population-based estimates of human immunodeficiency virus (HIV) antiretroviral therapy and Pneumocystis carinii prophylaxis use in HIV-infected men in 1991. Zidovudine, didanosine, and dideoxycytidine were the antiretroviral therapies and aerosolized pentamidine, trimethoprim-sulfamethoxazole, and dapsone were the Pneumocystis prophylaxis evaluated. Among 81 men (29 of whom had AIDS) with < or = 200 CD4 cells, 76 (94%) had ever used and 56 (69%) were currently using an antiretroviral drug; 73 (90%) had ever used and 61 (75%) were currently using Pneumocystis prophylaxis. Among 127 men with 201-499 CD4 cells, 95 (75%) had ever used and 81 (64%) were currently using antiretroviral therapy; 49 (39%) had ever used and 36 (28%) were currently using Pneumocystis prophylaxis. Among 122 men with > or = 500 CD4 cells, 29 (24%) were currently receiving antiretroviral therapy. Forty-three men had discontinued antiretroviral therapy, 29 (67%) because of side effects. Thirty-seven men with < or = 500 CD4 cells had never used antiretroviral drugs: 48% because of feeling well and 28% because of possible side effects. Compared with 1987-1989, there were substantial increases in both antiretroviral therapy and anti-Pneumocystis prophylaxis use. | lld:pubmed |
| pubmed-article:8381868 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8381868 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8381868 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8381868 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8381868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8381868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8381868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8381868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8381868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8381868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8381868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8381868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8381868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8381868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8381868 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8381868 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8381868 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:8381868 | pubmed:issn | 0894-9255 | lld:pubmed |
| pubmed-article:8381868 | pubmed:author | pubmed-author:LangWW | lld:pubmed |
| pubmed-article:8381868 | pubmed:author | pubmed-author:MossAA | lld:pubmed |
| pubmed-article:8381868 | pubmed:author | pubmed-author:WinkelsteinWW... | lld:pubmed |
| pubmed-article:8381868 | pubmed:author | pubmed-author:OsmondDD | lld:pubmed |
| pubmed-article:8381868 | pubmed:author | pubmed-author:Page-BodkinKK | lld:pubmed |
| pubmed-article:8381868 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8381868 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:8381868 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8381868 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8381868 | pubmed:pagination | 191-5 | lld:pubmed |
| pubmed-article:8381868 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:meshHeading | pubmed-meshheading:8381868-... | lld:pubmed |
| pubmed-article:8381868 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8381868 | pubmed:articleTitle | Population-based estimates of antiretroviral therapy and anti-Pneumocystis prophylaxis in San Francisco: 1991. | lld:pubmed |
| pubmed-article:8381868 | pubmed:affiliation | California Pacific Medical Center, San Francisco 94118. | lld:pubmed |
| pubmed-article:8381868 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8381868 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:8381868 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
